|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Ethyl-2-amino-6-bro- mo-6-( 1-cyano-2-ethoxy-2-oxoethyl ) -4H-chromene-3- carboxylate( HA 14-1 ), a prototype small-molecule an- tagonist against antiapoptotic Bcl-2 proteins, decom- poses to generate reactive oxygen species that induce apoptosis显示文摘 | DOSHI J M TIAN D XING C | 2007 | Mol Pharm2007，4，6： | 1 |
| 2 | sHA 14-1,a stable and ROS-free antagonist against anti-apoptotic Bcl-2 proteins,bypasses drug resistances and synergizes cancer therapies in human leukemia cell显示文摘 | Tian D Das S G Doshi J M | | 0，，02： | 1 |
| 3 | Limiting flux in ultrafiltration of macromolecular solutions显示文摘 | Trettin D R Doshi M R | 1980 | Chem Eng Commun1980，4，： | 1 |
| 4 | Optically, defined muhifunctional patterning of photosensitive thin-film silica mesophases显示文摘 | Doshi D A Huesing N K Lu M | 2000 | Science2000，290，： | 1 |
| 5 | Estimating the Proportion of Healthcare- Associated Infections that are Reasonably Preventable and the Related Mortality and Costs 显示文摘 | Umscheid C A Mitchell M D Doshi J A | 2011 | Infect Control Hosp Epidemiol2011，32，2： | 1 |
| 6 | Ethyl · 2 - amino - 6 - bromo - 4 - ( 1 - cyano -2 - ethoxy - 2 - oxoethyl ) - 4H - chromene - 3 - carboxylate( HA - 14 - 1 ) ,a prototype small - molecule antagonist against antiapoptotic Bcl - 2 proteins, decomposes to generate reactive oxygen species that induce apoptosis显示文摘 | Doshi J M Tian D Xing C | 2007 | Mol Pharm2007，4，6： | 1 |
| 7 | Ethyl-2-amino-6-bromo-4-( 1-cyano-2-ethoxy-2-oxoethyl )- 4H-chromene-3-carboxylate( HA 14-1 ) ,a prototype small-molecule antagonist against antiapoptotic Bcl-2 proteins, decomposes to generate reactive oxygen species that induce apoptosis 显示文摘 | Doshi J M Tian D Xing C | 2007 | Mol Pharm2007，4，6： | 1 |
| 8 | Structure-activity relationship studies of ethyl 2-amino-6-bromo-4-( 1-cyano-2-ethoxy-2- oxoethyl)- 4H-chromene-3-carboxylate ( HA 14-1 ), an antagonist for antiapoptotic Bcl-2 proteins to overcome drug resistance in cancer 显示文摘 | Doshi J M Tian D Xlng C | 2006 | J Med Chem2006，49，26： | 1 |
| 9 | Recipient risk fac- tors associated with delayed graft function: a paired kidney analysis显示文摘 | Doshi M D Garg N Reese P P | 2011 | Transplantation2011，91，6： | 1 |
| 10 | Thirty-minute application of the S-Caine peel prior to nonablative laser treatment 显示文摘 | Doshi S N Friedman P M Marquez D K ei al | 2003 | Dermatol Surg2003，29，10： | 1 |
| 11 | Structure-activity relationship studies of ethyl 2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate (HA 14-1),an antagonist for antiapoptotic Bcl-2 proteins to overcome drug resistance in cancer显示文摘 | Doshi J M Tian D Xing C | 2006 | J Med Chem2006，49，26： | 1 |
| 12 | Ethyl-2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl) -4H-chromene-3-carboxylate (HA 14-1),a prototype small-molecule antagonist against antiapoptotic Bcl-2 proteins,decomposes to generate reactive oxygen species that induce apoptosis显示文摘 | Doshi J M Tian D Xing C | 2007 | Mol Pharm2007，4，6： | 1 |
| 13 | sHA 14-1,a stable and ROS-free antagonist against anti-apoptotic Bcl-2 proteins,bypasses drug resistances and synergizes cancer therapies in human leukemia cell显示文摘 | Tian D Das S G Doshi J M | 2008 | Cancer Lett2008，259，2： | 1 |
| 14 | Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial显示文摘 | Holmes D R Reddy V Y Turi Z G Doshi S K Sievert H Buchbinder M | 2009 | Lancet2009，374，： | 1 |
| 15 | Preclinical evaluation of a new left atrial appendage occluder (Lifetech LAmbreTM Device) in a canine model显示文摘 | Lam Y Y Yan B P Doshi S K Li A Zhang D Kaya M G | 2013 | Int J Cardiol2013，168，： | 1 |
| 16 | Structure-activity re- lationship studies of ethyl 2-amino-6-bromo-4-( 1-cy- ano-2-ethoxy-2-oxoethyl ) -4H-chromene-3-carboxy- late(HA14-1 ), an antagonist for antiapoptotic Bcl-2 proteins to overcome drug resistance in cancer显示文摘 | DOSHI J M TIAN D X1NG C | 2006 | J Med Chem2006，49，26： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员